Authors: Ji Ma, Bert Malengier-Devlies, Babs E. Verstrepen, Yeranddy A. Alpizar, Thomas Vercruysse, Mahadesh Prasad Arkalagud Javarappa, Lorena Sanchez-Felipe, Gerrit Koopman, Natasja G. de Groot, Patrick Matthys, Johan Neyts, Ernst J. Verschoor, Lotte Coelmont, Hendrik Jan Thibaut, Johan Van… Read More »A vaccine against ZIKA Virus?
Authors: Ioannis Passarisa, Stéphanie Depickèreb, Chloé Abelsc, Jessica Vandenhautec, Raymond Vanhoofa, Pieter-Jan Ceyssensa a Bacterial Diseases Unit, Sciensano, Brussels, Belgium b Platform for Interventional Studies, Sciensano, Brussels, Belgium c MSD Belgium, Brussels, Belgium… Read More »Reshaping Adult Pneumococcal Disease Through Paediatric Vaccination
Authors: Lara Kelchtermans, Katrien Geerts, Cuong Thi Pham, Vanshika Malviya, Winston Chiu, Carolien De Keyzer, Elias Broeckhoven, Johan Neyts, Susan Schlenner, Yeranddy A. Alpizar & Kai Dallmeier Journal: Nature immunologyPublished: 25 March 2026DOI: https://doi.org/10.1038/s41590-026-02478-7 Abstract Recurring outbreaks… Read More »CD4+ T cell-mediated immunity protects from VSV-SUD lethal challenge in a mouse model of Sudan virus infection
About this white paper This white paper is an evidence-based call to action for Belgian policymakers on the implementation of tools required to eliminate HPV-related… Read More »Advancing public health: a roadmap to the implementation of tools required to eliminate HPV-related cancers and diseases in Belgium by 2030
Authors: Nicky de Vrij, Elise Pepermans, Louise Laurijssen, Thao-Thy Pham, Lauren Thijs, Kurt Boonen, Kadrie Ramadan, Ilse Maes, Yetemwork Aleka, Mekibib Kassa, Tigist Mekonnen, Mezgebu… Read More »Immunopeptidomics of cutaneous leishmaniasis patients reveals the natural antigenic landscape
Hannah R. Volkman , Leonie de Munter, Jennifer L. Nguyen, Thao M. P. Tran, Marianna itratza,Cátia Marques, Laura Choi, Srinivas Valluri, Jingyan Yang, Andrés Antón, Irma… Read More »Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform
Emily Rayens, Lina S. Sy, Lei Qian, Bradley K. Ackerson, Julia Tubert, Yi Luo, Punam P. Modha, Raul O. Calderon, Elizabeth Chmielewski-Yee, Driss Oraichi, Huifeng Yun, Carol Koro & Hung Fu Tseng. Journal: Nature CommunicationsPublished: 09 February 2026DOI:… Read More »Recombinant zoster vaccine is associated with a reduced risk of dementia
Authors: Pablo Tsukayama et al. , in collaboration with UAntwerp, Global Health Institute. Abstract Background: Peru recorded one of the world’s highest COVID-19 mortality rates,… Read More »Genomic epidemiology of SARS-CoV-2 in Peru from 2020 to 2024
Review article The global surge in antimicrobial resistance presents a critical threat to public health, emphasizing the urgent need for the development of new and… Read More »Challenges and opportunities in mRNA vaccine development against bacteria
This study reveals how ETEC’s heat-labile enterotoxin (LT) compromises porcine monocyte viability and immune function — providing new insights into the pathogen’s immunomodulatory strategies. Authors:Jinglin… Read More »Enterotoxigenic Escherichia coli heat-labileenterotoxin induces cell death and disruptseffector functions in porcine monocytes
